sumatriptan has been researched along with Polycythemia Vera in 1 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Polycythemia Vera: A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Migraines affect approximately 10% of the adult population worldwide." | 2.73 | A unique iontophoretic patch for optimal transdermal delivery of sumatriptan. ( Dubé, LM; Jackson, D; Kaldeway, P; Morris, R; O'Neill, C; Sebree, T; Siegel, SJ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siegel, SJ | 1 |
| O'Neill, C | 1 |
| Dubé, LM | 1 |
| Kaldeway, P | 1 |
| Morris, R | 1 |
| Jackson, D | 1 |
| Sebree, T | 1 |
1 trial available for sumatriptan and Polycythemia Vera
| Article | Year |
|---|---|
A unique iontophoretic patch for optimal transdermal delivery of sumatriptan.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Chemistry, Pharmaceutical; Drug Delivery Sys | 2007 |